scispace - formally typeset
G

Gerlinde Averous

Researcher at University of Strasbourg

Publications -  65
Citations -  673

Gerlinde Averous is an academic researcher from University of Strasbourg. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 11, co-authored 47 publications receiving 547 citations.

Papers
More filters
Journal ArticleDOI

Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.

TL;DR: Uterine PEComa is a rare tumor whose diagnostic criteria are being recently defined as discussed by the authors , and the integration of molecular data with dedicated expert pathology review for histology and clinical data allows better identification of uterine sarcomas in order to better treat them.
Journal ArticleDOI

Que deviennent les CIN2 diagnostiquées sur biopsie

TL;DR: La persistance/progression a ete definie comme le constat d’une CIN2/CIN3 sur conisation, biopsie ou frottis ulterieurs et la regression comme absence de lesion ou CIN1, contrairement a la prise de contraceptifs oraux et l’infection a HPV16/18 persistante.
Journal ArticleDOI

Prognostic significance of residual lymphovascular invasion after resection of locally advanced and borderline resectable pancreatic adenocarcinomas treated by neoadjuvant chemotherapy.

TL;DR: The persistence of LVI at pathology after resection of locally advanced and borderline pancreatic adenocarcinomas treated by neoadjuvant chemotherapy predicts poor response and limited long-term survival.
Journal ArticleDOI

Real case of primitive embryonal duodenal carcinoma in a young man.

TL;DR: The patient was a 25-year-old man who was referred to the authors' centre for asthenia, stinging epigastric pain, and an iron deficiency anaemia and Histological findings were suggestive of a duodenal embryonal carcinoma with pancreatic infiltration.
Journal ArticleDOI

External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification.

TL;DR: In this article , a prospective analysis of samples from a historical and international cohort of patients was carried out to carry out an external and multicentre validation of this new proposed classification.